Drug
Combination Therapy Phase I
Combination Therapy Phase I: highest development phase Phase 1/2, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| Combination therapy (S81694 + paclitaxel) phase I NCT03411161 | Phase 1/2 | Metastatic Breast Cancer |
Latest
No recent events.
Follow Combination Therapy Phase I on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.